AHA Scientific Sessions 2025 Abstract
Soluble Urokinase Plasminogen Activator Receptor (suPAR), Lipoprotein(a), and Cardiovascular Outcomes in the Multi-Ethnic Study of Atherosclerosis (MESA)
Cohort study of 4,357 peopleLipoprotein
Composite cardiovascular outcome (all-cause death, CVD death, myocardial infarction, or stroke)
Papers on composite cardiovascular outcome (all-cause death, CVD death, myocardial infarction, or stroke)
1 paper